As cytostatic drugs move from manufacturing facilities to patients, a specialized logistics infrastructure must guarantee their integrity and safety.
Source: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-4/2013-06_gdp_guidelines.pdf
Matching tools and partners
You might also be interested in these terms
Verified forwarders, ranked by coverage and profile — premium capped at 10%.
Free · No password · Never a paywall. Weekly top news and facts from logistics.
Content reviewed and editorially cleared.
Share your knowledge, ask follow-up questions, or add practical insights to this page. Every contribution is moderated before publication.